ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting
· vianautis
AI Briefing
- ViaNautis Bio presents targeted polyNaut nanovesicles for in vivo CAR-T therapies at ASGCT Annual Meeting.
- CAR-T therapies utilize tPNVs for immune system targeting.
- Presentation aims to advance cancer treatment with enhanced efficacy and reduced side effects.
Advertisement